Skip to main content
. 2025 Feb 24;14(2):1214–1222. doi: 10.21037/tcr-24-1226

Figure 1.

Figure 1

The nomogram for predicting 1-, 3-, 5-year OS of HCC patients with MVI after treatment TACE combined with IMRT. TACE, transcatheter arterial chemoembolization; AFP, alpha fetoprotein; OS, overall survival; HCC, hepatocellular carcinoma; MVI, macrovascular invasion; IMRT, intensity modulated radiotherapy.